NASDAQ:CBAY
CymaBay Therapeutics Inc
- Stock
industry
Biotechnologyexchange
NASDAQ Global Selectwebsite
www.cymabay.comipo date
Jan 16, 2014full time employees
60currency
USD
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in pha...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus
founders
- Sujal Shah
num employees
- 51-100